[PDF][PDF] Cognitive deficit in schizophrenia: an overview
A Mihaljević-Peleš, M Bajs Janović, M Šagud… - Psychiatria …, 2019 - hrcak.srce.hr
Depressive mood, anxiety, delusions, hallucinations and behavioral disturbances have
been traditionally recognized as leading symptoms of mental disorders. However, cognitive …
been traditionally recognized as leading symptoms of mental disorders. However, cognitive …
Depression and stress levels in patients with different psychiatric disorders during concurrent early-phase COVID-19 pandemic and earthquake in Croatia
Abstract Background While Croatia shared COVID-19 pandemic with other countries, its
capital area was also hit by a 5.6 magnitude earthquake. The simultaneous impact of these …
capital area was also hit by a 5.6 magnitude earthquake. The simultaneous impact of these …
Применение антипсихотиков длительного действия при шизофрении
ЖБ Бибекова, ЕА Стрельцов… - … вестник Юга России, 2020 - cyberleninka.ru
В настоящем обзоре литературы рассмотрены вопросы эффективности и
безопасности терапии антипсихотиками длительного действия при шизофрении …
безопасности терапии антипсихотиками длительного действия при шизофрении …
Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands
TR Einarson, BG Bereza, F Tedouri… - Journal of medical …, 2017 - Taylor & Francis
Background: A new depot formulation of paliperidone has been developed that provides
effective treatment for schizophrenia for 3 months (PP3M). It has been tested in phase-3 …
effective treatment for schizophrenia for 3 months (PP3M). It has been tested in phase-3 …
Rate of and time to symptomatic remission in first-episode psychosis in Northern Malawi: A STROBE-compliant article
AC Kaminga, W Dai, A Liu, J Myaba, R Banda… - Medicine, 2018 - journals.lww.com
Although longer duration of untreated psychosis (DUP) is associated with poor response to
antipsychotic treatment, it remains unclear whether it independently influences time to …
antipsychotic treatment, it remains unclear whether it independently influences time to …
[PDF][PDF] Şizofreni hastalığına sahip bireylerin çalışma hayatı konusunda yaşadıkları güçlükler
I Işık, G Savaş, N Kılıç - Acıbadem Üniversitesi Sağlık Bilimleri …, 2019 - dergipark.org.tr
Bu çalışma şizofreni hastalarının iş bulma ve iş hayatında yaşadıkları güçlükleri belirlemek
amacıyla fenomenolojik tipte yapılmış bir araştırmadır. Araştırma, amaca yönelik örneklem …
amacıyla fenomenolojik tipte yapılmış bir araştırmadır. Araştırma, amaca yönelik örneklem …
[HTML][HTML] The effects of paliperidone palmitate 1 month on the employment status and social functioning of patients with schizophrenia
T Ohnishi, H Kobayashi, T Yamaoka… - Innovations in Clinical …, 2020 - ncbi.nlm.nih.gov
Objective: We sought to evaluate the effects of a one-month paliperidone palmitate
formulation (PP1M) on employment status, social function, symptomatology, and safety and …
formulation (PP1M) on employment status, social function, symptomatology, and safety and …
Factors predicting relapse and treatment discontinuation with paliperidone 3-monthly long-acting injection: A 2-year naturalistic follow-up study
BackgroundPaliperidone 3-monthly (PP3M) long-acting injection has proven efficacy and
effectiveness in schizophrenia. Little is known of its effectiveness in other diagnoses …
effectiveness in schizophrenia. Little is known of its effectiveness in other diagnoses …
Remission is not associated with DRD2 rs1800497 and DAT1 rs28363170 genetic variants in male schizophrenic patients after 6-months monotherapy with …
M Zivkovic, A Mihaljevic-Peles, D Muck-Seler… - Psychiatria …, 2020 - hrcak.srce.hr
REMISSION IS NOT ASSOCIATED WITH DRD2 RS1800497 AND DAT1 RS28363170 GENETIC
VARIANTS IN MALE SCHIZOPHRENIC PATIENTS AFTER 6-MON Page 1 84 Psychiatria …
VARIANTS IN MALE SCHIZOPHRENIC PATIENTS AFTER 6-MON Page 1 84 Psychiatria …
[PDF][PDF] Somatic symptom disorder responding to risperidone treatment
F Kurhan, S Aktas - Psychiatria Danubina, 2023 - hrcak.srce.hr
The disease which was named as Somatoform Disorder in DSM-III (The Diagnostic and
Statistical Manual of Mental Disorders, Third Edition) and remained unchanged in DSM-IV …
Statistical Manual of Mental Disorders, Third Edition) and remained unchanged in DSM-IV …